WOODMONT INVESTMENT COUNSEL LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 113 filers reported holding GW PHARMACEUTICALS PLC in Q1 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOODMONT INVESTMENT COUNSEL LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2017$203,000
+1.0%
2,0000.0%0.06%
-3.5%
Q2 2017$201,000
+1446.2%
2,000
+1900.0%
0.06%
+1325.0%
Q3 2016$13,000
-7.1%
100
-50.0%
0.00%0.0%
Q1 2016$14,0000.0%2000.0%0.00%0.0%
Q4 2015$14,000
-22.2%
2000.0%0.00%
-20.0%
Q3 2015$18,000
-25.0%
2000.0%0.01%
+25.0%
Q2 2015$24,0002000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders